Home | 2 Minute Medicine
WEB2 Minute Medicine Rewind September 16, 2024. by Jayden Berdugo and 1 others. September 16, 2024. Sleep patterns, physical activity, genetic susceptibility, and incident rheumatoid arthritis: a prospective cohort study 1. In this prospective cohort study, a healthy sleep pattern and moderate levels of physical activity...
Exoskeletal assisted walking devices currently do not demonstrate …
WEBSep 14, 2024 — 1. In veterans with spinal cord injuries, exoskeletons showed no clear benefits (medical, physical or psychological) compared to standard wheelchair use 2. Exoskeleton technology is still not adopted readily with participants only using the devices an average of 86 minutes per week Evidence Rating Level: 1 (Excellent) Spinal cord injuries (SCI) often result in severe
Biguanides and dipeptidyl peptidase-4 inhibitors use have similar ...
WEBAug 16, 2024 — 1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death in the Japanese population. Evidence Rating Level: 2 (Good) The initial pharmacologic intervention for type 2 diabetes mellitus (T2DM) includes biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patient Basics: Seizure - 2 Minute Medicine
WEBNov 30, 2014 — A seizure is a sudden change in the brain's normal electrical activity. During a seizure, brain cells "fire" uncontrollably at up to four times their normal rate, temporarily affecting the way a person behaves, moves, thinks or feels. There are two major types of seizures: Primary generalized seizures.
The COMMIT trial: Metoprolol and clopidogrel in patients with …
WEBSep 25, 2013 — Image: PD 1. Adding early metoprolol does not further decrease the risk of death post-MI compared to conventional fibrinolytic therapy alone. 2. Use of early metoprolol decreases the risk of reinfarction and ventricular fibrillation, but increases the risk of cardiogenic shock. 3. Adding clopidogrel to aspirin decreases the combined risk of death, reinfarction, or stroke
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
WEBA deep understanding of these trials is paramount for every physician, healthcare professional, and trainee, as it lays the foundation for evidence-based clinical decisions made daily. 2MM+ Subscriber Exclusive Access: The Online Edition of The Classics Series™ includes The Classics in Medicine™ textbook and all deep-dive sub-specialty ...
The RALES trial: Spironolactone decreases all-cause mortality in …
WEBApr 9, 2014 — Image: PD 1. Adding 25 mg of spironolactone to standard therapy reduces all-cause mortality in heart failure patients with an ejection fraction <35% Original Date of Publication: September 2, 1999 Study Rundown: This landmark study supported the use of spironolactone, in addition to standard medical therapy, to reduce mortality and hospitalizations in patients with heart failure.
Mediterranean diet effects on vascular health and serum levels of ...
WEBAug 15, 2024 — 1. The effect of the Mediterranean Diet on cardiovascular health can be partially explained by improved vascular health, lowered total cholesterol and LDL, lowered ceramides, and reduced serum inflammatory adipokines. Evidence Rating Level: 1 (Excellent) Study Rundown: The Mediterranean Diet has been previously shown to improve cardiovascular outcomes in patients.
The ARMA trial: Lower tidal volume ventilation in ALI/ARDS …
WEB1. The trial was terminated early when the data demonstrated that lower tidal volume ventilator settings in ALI/ARDS patients led to a significant decrease in in-hospital mortality. 2. Low tidal volume ventilation also led to an increase in ventilator-free days and a decrease in the number of days with systemic organ failure. There was no.
Biomarkers may help guide antibiotic stewardship in community …
WEBAug 26, 2024 — 1. Using either procalcitonin or c-reactive protein as a biomarker to guide antibiotic treatment in patients with community-acquired pneumonia reduces the length of treatment course with no effect to time to reach stability or new antibiotic prescriptions Evidence Rating Level: 1 (Excellent) 20-50% of the 3.3 million people who develop community-acquired pneumonia (CAP) need to
Skip to content